Literature DB >> 25102088

Is it safe to drop CD4+ monitoring among virologically suppressed patients: a cohort evaluation from Khayelitsha, South Africa.

Nathan Ford, Kathryn Stinson, Mary-Ann Davies, Vivian Cox, Gabriela Patten, Carol Cragg, Gilles Van Cutsem, Andrew Boulle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25102088     DOI： 10.1097/QAD.0000000000000406

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  14 in total

1.  Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression.

Authors:  Jin Young Ahn; David Boettiger; Matthew Law; Nagalingeswaran Kumarasamy; Evy Yunihastuti; Romanee Chaiwarith; Man Po Lee; Benedict L H Sim; Shinichi Oka; Wingwai Wong; Adeeba Kamarulzaman; Pacharee Kantipong; Praphan Phanuphak; Oon Tek Ng; Sasisopin Kiertiburanakul; Fujie Zhang; Sanjay Pujari; Rossana Ditangco; Winai Ratanasuwan; Tuti Parwati Merati; Vonthanak Saphonn; Annette H Sohn; Jun Yong Choi
Journal:  J Acquir Immune Defic Syndr       Date:  2015-07-01       Impact factor: 3.731

2.  A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey.

Authors:  Jonathan M Kagan; Ana M Sanchez; Alan Landay; Thomas N Denny
Journal:  For Immunopathol Dis Therap       Date:  2015

3.  Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.

Authors:  Mary-Ann Davies; Nathan Ford; Helena Rabie; Geoffrey Fatti; Kathryn Stinson; Janet Giddy; Frank Tanser; Karl-Günter Technau; Shobna Sawry; Brian Eley; Robin Wood; Lynne M Mofenson; Olivia Keiser; Andrew Boulle
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

4.  Quantitative Assessment of Intra-Patient Variation in CD4+ T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected Subjects.

Authors:  Claire L Gordon; Allen C Cheng; Paul U Cameron; Michael Bailey; Suzanne M Crowe; John Mills
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

5.  Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

Authors:  Antonio Di Biagio; Marta Ameri; Davide Sirello; Giovanni Cenderello; Enrico Di Bella; Lucia Taramasso; Barbara Giannini; Mauro Giacomini; Claudio Viscoli; Giovanni Cassola; Marcello Montefiori
Journal:  BMC Infect Dis       Date:  2017-02-06       Impact factor: 3.090

6.  Low Risk of CD4 Decline After Immune Recovery in Human Immunodeficiency Virus-Infected Children With Viral Suppression.

Authors:  Pope Kosalaraksa; David C Boettiger; Torsak Bunupuradah; Rawiwan Hansudewechakul; Sarun Saramony; Viet C Do; Tavitiya Sudjaritruk; Nik K N Yusoff; Kamarul A M Razali; Lam V Nguyen; Revathy Nallusamy; Siew M Fong; Nia Kurniati; Khanh H Truong; Annette H Sohn; Kulkanya Chokephaibulkit
Journal:  J Pediatric Infect Dis Soc       Date:  2017-06-01       Impact factor: 3.164

Review 7.  CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis.

Authors:  Nathan Ford; Kathryn Stinson; Howard Gale; Edward J Mills; Wendy Stevens; Mercedes Pérez González; Mercedes P González; Jessica Markby; Andrew Hill
Journal:  J Int AIDS Soc       Date:  2015-08-07       Impact factor: 5.396

8.  Derivation and validation of an accurate estimation of CD4 counts from the absolute lymphocyte count in virologically suppressed and immunologically reconstituted HIV infected adults.

Authors:  Barnaby Young; Oon Tek Ng; David Chien Lye; Yee Sin Leo
Journal:  BMC Infect Dis       Date:  2015-08-13       Impact factor: 3.090

9.  Implementation and Operational Research: CD4 Count Monitoring Frequency and Risk of CD4 Count Dropping Below 200 Cells Per Cubic Millimeter Among Stable HIV-Infected Patients in New York City, 2007-2013.

Authors:  Julie E Myers; Qiang Xia; Lucia V Torian; Mary Irvine; Graham Harriman; Kent A Sepkowitz; Colin W Shepard
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

10.  Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.

Authors:  T B Leeme; M Mine; K Lechiile; F Mulenga; M Mosepele; T Mphoyakgosi; C Muthoga; J Ngidi; B Nkomo; D Ramaabya; M Tau; M W Tenforde; R Hayes; J N Jarvis
Journal:  HIV Med       Date:  2020-09-02       Impact factor: 3.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.